AP FRANK JOBE

Frank Jobe, inventor of Tommy John surgery, passes away at age 88

17 Comments

Sad news to pass along this evening, as Tommy John surgery pioneer Dr. Frank Jobe has passed away at the age of 88.

Jobe worked for the Dodgers for 50 years and is best known for performing the first-ever unlar collateral ligament reconstructive elbow surgery on left-handed pitcher Tommy John on September 25, 1974. While it was a last-ditch effort to save his career, John went on to pitch 14 more seasons.

The procedure, which would eventually be known as Tommy John surgery, changed the sport and has extended the careers of countless pitchers. Jobe was honored in Cooperstown last July for the groundbreaking surgery, but many have argued that he belongs in the Hall of Fame. It’s hard to think of many people who have had a bigger impact on the game of baseball.

Here’s a statement from Dodgers president Stan Kasten:

“Frank Jobe is a Hall of Famer in every sense of the word. His dedication and professionalism in not only helping the Dodgers, but athletes around the world is unparalleled. He was a medical giant and pioneer and many athletes in the past and the future can always thank Frank for finding a way to continue their careers.”

MLB commissioner Bud Selig has also released a statement:

“I was deeply saddened to learn of the loss of Dr. Frank Jobe, a great gentleman whose work in Baseball revolutionized sports medicine. Since 1974, his groundbreaking Tommy John surgery has revitalized countless careers, especially those of our pitchers. His wisdom elevated not only the Dodgers, the franchise he served proudly for a half-century, but all of our Clubs.”

“Dr. Jobe’s expertise, as well as his enthusiasm to mentor his peers, made the National Pastime stronger. On behalf of Major League Baseball, I extend my deepest condolences to Dr. Jobe’s family, friends, Dodger colleagues and the many admirers of his pioneering spirit throughout our game.”

Rest in peace, Dr. Jobe. And thanks.

Red Sox could go to arbitration hearing with Fernando Abad

BOSTON, MA - SEPTEMBER 16:  Fernando Abad #58 of the Boston Red Sox pitches against the New York Yankees during the ninth inning at Fenway Park on September 16, 2016 in Boston, Massachusetts.  (Photo by Maddie Meyer/Getty Images)
Getty Images
Leave a comment

The Red Sox are expecting to go to an arbitration hearing with left-handed reliever Fernando Abad, per Pete Abraham of the Boston Globe. Red Sox president Dave Dombrowski said there was a “decent chance” a hearing would be necessary after countering Abad’s $2.7 million request with $2 million.

Abad, 31, pitched just 12 2/3 innings for Boston after the club acquired him from Minnesota at the trade deadline last season. The lefty earned a cumulative 3.66 ERA, 4.2 BB/9 and 7.9 SO/9 for the two teams in 2016. He received $1.25 million in 2016 and will remain under club control (through arbitration) in 2017. A $2.7 million salary would be a hefty increase for the veteran reliever, who has seen a significant decline since he put up a 1.57 ERA for the Athletics in 2014 and who has not amassed more than 0.6 fWAR in any single season to date.

While the Red Sox aren’t close to settling with Abad, Evan Drellich of the Boston Herald reports that they may be closing in on a settlement with left-handed starter Drew Pomeranz. Pomeranz filed at $5.7 million, while the Sox felt more comfortable at $3.6 million. The two are expected to meet somewhere in the middle to avoid an arbitration hearing later this winter.

Report: Braves sign Kurt Suzuki

KANSAS CITY, MO - AUGUST 20: Kurt Suzuki #8 of the Minnesota Twins hits against the Kansas City Royals at Kauffman Stadium on August 20, 2016 in Kansas City, Missouri. (Photo by Ed Zurga/Getty Images)
Getty Images
1 Comment

The Braves reportedly have a deal in place with free agent catcher Kurt Suzuki, per Chris Cotillo of SB Nation. FOX Sports’ Ken Rosenthal adds that the contract is for one year, $1.5 million with up to $2.5 million in additional incentives.

Suzuki, 33, completed a three-year track with the Twins in 2016, slashing .258/.301/.403 with eight home runs in 373 PA. The veteran backstop likely won’t provide an offensive or defensive upgrade over current starter Tyler Flowers, but should give the Braves some depth at a position they’ve been looking to strengthen since the start of the offseason.

The team has yet to confirm the deal.